CorFlow Therapeutics AG develops and validates the CoFl system for diagnosing and treating Microvascular Obstruction (MVO) in heart attack patients.

Laza Medical, Inc. specializes in developing AI-powered robotically-assisted imaging technologies to enhance cardiovascular interventions.

Carthera is a medtech company that develops innovative ultrasound-based devices to treat brain disorders by temporarily opening the Blood-Brain Barrier, currently focusing on clinical trials for treating recurrent glioblastoma with their SonoCloud technology.

Supira Medical, Inc. is developing the Supira System, a percutaneous ventricular assist device (pVAD) designed to provide hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients.